amiodarone has been researched along with Bradycardia in 77 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dronedarone is a new antiarrhythmic drug that is being developed for the treatment of patients with atrial fibrillation." | 9.14 | Effect of dronedarone on cardiovascular events in atrial fibrillation. ( Connolly, SJ; Crijns, HJ; Gaudin, C; Hohnloser, SH; Page, RL; Torp-Pedersen, C; van Eickels, M, 2009) |
| "Intraoperative prophylactic use of amiodarone does not prevent new onset of atrial fibrillation in patients undergoing coronary artery bypass grafting and had no effect on outcome." | 9.09 | Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. ( Dörge, H; Messmer, BJ; Schoberer, M; Schoendube, FA; Stellbrink, C; Voss, M, 2000) |
| "If tolerated, continuous intravenous verapamil infusion showed only a modest prophylactic efficacy for the occurrence of atrial fibrillation after lung operations." | 9.08 | Verapamil as prophylactic treatment for atrial fibrillation after lung operations. ( Demedts, M; Demuynck, K; Deneffe, G; Lacquet, L; Tits, G; Tjandra-Maga, T; Van Mieghem, W, 1996) |
| "MEDLINE search of published, randomized, controlled trials assessing the efficacy and safety of intravenous amiodarone in recent-onset (< 7 days) atrial fibrillation, supplemented with searches of reference lists of identified articles and bibliographies of secondary and tertiary review articles." | 8.81 | Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. ( Hilleman, DE; Spinler, SA, 2002) |
| "The use of amiodarone for postoperative atrial fibrillation (AF) is widespread; however, there is a paucity of data on the optimal duration of overlap when transitioning from intravenous (IV) to oral amiodarone." | 8.12 | Intravenous to Oral Transition of Amiodarone (IOTA): Effect of Various Durations of Overlap on Atrial Fibrillation Recurrence After Cardiothoracic Surgery. ( Lam, JC; Lee, YG; Maurer, J; Patanwala, AE; Radosevich, JJ; Stevenson, B, 2022) |
| "Amiodarone, prescribed for cardiac conditions, including dysrhythmia, is associated with bradycardia." | 7.96 | Severe Bradycardia Induced by Sofosbuvir and Amiodarone which Resolved after the Discontinuation of Both Drugs. ( Funakoshi, H; Kitaguchi, K; Monoe, C; Shimizu, H, 2020) |
| " In 2015, the Food and Drug Administration and European Medical Agency warned that bradycardia could occur when amiodarone was administered in combination with sofosbuvir, but no case reports had been published." | 7.81 | Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge. ( Algalarrondo, V; Antonini, T; Chaumais, MC; Duclos-Vallée, JC; Renet, S; Samuel, D; Savoure, A; Thomas, L; Zhao, A, 2015) |
| "Cardiac disorders caused by sofosbuvir are liable to be worsened by concomitant use of one of the many drugs that provoke cardiac arrhythmia." | 7.81 | Sofosbuvir + amiodarone: bradycardia and conduction disturbances. ( , 2015) |
| "Our study showed that during the intra- and postoperative periods, both amiodarone and magnesium sulfate are effective at preventing the incidence of atrial fibrillation following lung resection surgery in comparison to the control group." | 7.79 | A comparative study between amiodarone and magnesium sulfate as antiarrhythmic agents for prophylaxis against atrial fibrillation following lobectomy. ( Abdel Azeem, MS; Al-Agaty, AE; Ali, WG; Khalil, MA, 2013) |
| "This study suggests that the use of amiodarone in elderly patients with AF and a previous MI increases the risk of bradyarrhythmia requiring a permanent pacemaker." | 7.72 | Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. ( Essebag, V; Hadjis, T; Pilote, L; Platt, RW, 2003) |
| "Gestational exposure to amiodarone may be complicated by perinatal hypothyroidism or hyperthyroidism and possibly neurologic abnormalities, intrauterine growth retardation or fetal bradycardia." | 7.69 | Pregnancy outcome after gestational exposure to amiodarone in Canada. ( Allen, LC; Boulton, BC; Downar, E; Koren, G; Magee, LA; Sermer, M, 1995) |
| "In 23 patients with symptomatic severe supraventricular and ventricular tachyarrhythmias the effectiveness and the side effects of a long-term therapy with the class III antiarrhythmic drug Amiodarone (Cordarone) in a dosage of 100-800 mg/die in monotherapy and combination therapy were investigated." | 7.67 | [Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects]. ( Assmann, I, 1985) |
| "Amiodarone, 600 mg orally daily, was used in an attempt to control supraventricular tachyarrhythmias in a patient with the sick sinus syndrome." | 7.66 | Amiodarone-induced ventricular fibrillation. ( Adgey, AA; Geddes, JS; Khan, MM; Logan, KR; McComb, JM, 1980) |
| "Five patients with the bradycardia-tachycardia syndrome have been treated successfully with the antiarrhythmic agent amiodarone." | 7.66 | Use of amiodarone in bradycardia-tachycardia syndrome. ( Brown, AK; Newton, P; Primhak, RA, 1978) |
| "Bradycardia was observed less in the study group (76 ± 29) than in the control group (93 ± 18; P < ." | 6.79 | Effectiveness of biatrial epicardial application of amiodarone-releasing adhesive hydrogel to prevent postoperative atrial fibrillation. ( Feng, XD; Wang, W; Wang, XN; Yuan, XH, 2014) |
| "Amiodarone has been shown to improve survival in patients with impaired left ventricular function and ventricular trachyarrhythmias." | 5.29 | [Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders]. ( Hofmann, R; Leisch, F, 1995) |
| "Dronedarone is a new antiarrhythmic drug that is being developed for the treatment of patients with atrial fibrillation." | 5.14 | Effect of dronedarone on cardiovascular events in atrial fibrillation. ( Connolly, SJ; Crijns, HJ; Gaudin, C; Hohnloser, SH; Page, RL; Torp-Pedersen, C; van Eickels, M, 2009) |
| "Intraoperative prophylactic use of amiodarone does not prevent new onset of atrial fibrillation in patients undergoing coronary artery bypass grafting and had no effect on outcome." | 5.09 | Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. ( Dörge, H; Messmer, BJ; Schoberer, M; Schoendube, FA; Stellbrink, C; Voss, M, 2000) |
| "If tolerated, continuous intravenous verapamil infusion showed only a modest prophylactic efficacy for the occurrence of atrial fibrillation after lung operations." | 5.08 | Verapamil as prophylactic treatment for atrial fibrillation after lung operations. ( Demedts, M; Demuynck, K; Deneffe, G; Lacquet, L; Tits, G; Tjandra-Maga, T; Van Mieghem, W, 1996) |
| " β blockers, alone or in combination with digoxin, or non-dihydropyridine calcium-channel blockers (not in heart failure) effectively lower the heart rate." | 4.93 | Rate control in atrial fibrillation. ( Crijns, HJ; Olshansky, B; Rienstra, M; Van Gelder, IC, 2016) |
| "Amiodarone remains one of the preferred antiarrhythmic medications for patients with advanced heart failure awaiting cardiac transplant." | 4.91 | Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients. ( Jennings, DL; Lanfear, DE; Martinez, B; Montalvo, S, 2015) |
| "MEDLINE search of published, randomized, controlled trials assessing the efficacy and safety of intravenous amiodarone in recent-onset (< 7 days) atrial fibrillation, supplemented with searches of reference lists of identified articles and bibliographies of secondary and tertiary review articles." | 4.81 | Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials. ( Hilleman, DE; Spinler, SA, 2002) |
| "Amiodarone, an investigational drug in the United States, has had considerable use in this country and worldwide in the treatment of cardiac arrhythmias." | 4.76 | Clinical use and pharmacology of amiodarone. ( Heger, JJ; Miles, WM; Prystowsky, EN; Zipes, DP, 1984) |
| "The use of amiodarone for postoperative atrial fibrillation (AF) is widespread; however, there is a paucity of data on the optimal duration of overlap when transitioning from intravenous (IV) to oral amiodarone." | 4.12 | Intravenous to Oral Transition of Amiodarone (IOTA): Effect of Various Durations of Overlap on Atrial Fibrillation Recurrence After Cardiothoracic Surgery. ( Lam, JC; Lee, YG; Maurer, J; Patanwala, AE; Radosevich, JJ; Stevenson, B, 2022) |
| "Amiodarone, prescribed for cardiac conditions, including dysrhythmia, is associated with bradycardia." | 3.96 | Severe Bradycardia Induced by Sofosbuvir and Amiodarone which Resolved after the Discontinuation of Both Drugs. ( Funakoshi, H; Kitaguchi, K; Monoe, C; Shimizu, H, 2020) |
| "Administration of acute or chronic pretransplant amiodarone was not related to an increased occurrence of bradycardia, requirement for permanent pacemaker implantation, or mortality after HTX." | 3.85 | Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation. ( Bruckner, T; Darche, FF; Doesch, AO; Helmschrott, M; Katus, HA; Rivinius, R; Ruhparwar, A; Thomas, D, 2017) |
| "Cardiac disorders caused by sofosbuvir are liable to be worsened by concomitant use of one of the many drugs that provoke cardiac arrhythmia." | 3.81 | Sofosbuvir + amiodarone: bradycardia and conduction disturbances. ( , 2015) |
| " In 2015, the Food and Drug Administration and European Medical Agency warned that bradycardia could occur when amiodarone was administered in combination with sofosbuvir, but no case reports had been published." | 3.81 | Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge. ( Algalarrondo, V; Antonini, T; Chaumais, MC; Duclos-Vallée, JC; Renet, S; Samuel, D; Savoure, A; Thomas, L; Zhao, A, 2015) |
| "Between January 1, 2000 and March 10, 2012, a total of 930 consecutive patients who had been treated with amiodarone for arrhythmia were reviewed retrospectively." | 3.80 | The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice. ( Chung, WY; Kim, HL; Kim, MA; Kim, SH; Seo, JB; Zo, JH, 2014) |
| "Multiple studies have shown that amiodarone is effective in treating atrial fibrillation (AF), but is associated with a relatively high incidence of side effects; however, due to amiodarone's long elimination half-life (20-100 days), physicians may hesitate to start other drugs until it has fully cleared." | 3.79 | Effects of dronedarone started rapidly after amiodarone discontinuation. ( Aliot, E; Capucci, A; Connolly, S; Crijns, H; Hohnloser, S; Immordino, L; Kowey, P; Radzik, D; Roy, D, 2013) |
| "Our study showed that during the intra- and postoperative periods, both amiodarone and magnesium sulfate are effective at preventing the incidence of atrial fibrillation following lung resection surgery in comparison to the control group." | 3.79 | A comparative study between amiodarone and magnesium sulfate as antiarrhythmic agents for prophylaxis against atrial fibrillation following lobectomy. ( Abdel Azeem, MS; Al-Agaty, AE; Ali, WG; Khalil, MA, 2013) |
| "Treatment with amiodarone is often associated with sinus bradycardia." | 3.74 | [Effect of treatment with amiodarone on sinus node function]. ( Reĭngardene, DI, 2007) |
| "Amiodarone and cedilanid may be the proper drugs for the treatment of paroxysmal atrial fibrillation in the elderly." | 3.73 | Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old. ( Cao, J; Chen, DY; Zhu, BP, 2006) |
| "This study suggests that the use of amiodarone in elderly patients with AF and a previous MI increases the risk of bradyarrhythmia requiring a permanent pacemaker." | 3.72 | Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. ( Essebag, V; Hadjis, T; Pilote, L; Platt, RW, 2003) |
| "Bradyarrhythmia requiring permanent pacemaker insertion has been associated with amiodarone use but the effect of amiodarone dose has not been investigated." | 3.72 | Effect of amiodarone dose on the risk of permanent pacemaker insertion. ( Abrahamowicz, M; Essebag, V; Hadjis, T; Pilote, L; Platt, RW, 2004) |
| "Gestational exposure to amiodarone may be complicated by perinatal hypothyroidism or hyperthyroidism and possibly neurologic abnormalities, intrauterine growth retardation or fetal bradycardia." | 3.69 | Pregnancy outcome after gestational exposure to amiodarone in Canada. ( Allen, LC; Boulton, BC; Downar, E; Koren, G; Magee, LA; Sermer, M, 1995) |
| "Recurrent atypical ventricular tachycardia, with a long QT interval, was documented in a 56-year-old patient 16 days after discontinuing amiodarone 200 mg and 400 mg on alternate days." | 3.67 | Torsade de pointes after amiodarone withdrawal; effects of mild hypokalaemia on repolarization. ( Forfar, JC; Gribbin, B, 1984) |
| " Individual differences between the longest and the shortest RV MAP durations indicate that: normally (40 subjects) ventricular repolarization is almost synchronous; QT prolongation due either to bradycardia or to amiodarone treatment (eight cases) may be the result of a uniform lengthening of ventricular repolarization, when ventricular arrhythmias are not present; in long QT syndromes (LQTSs) of differing etiology (10 cases), in which severe ventricular arrhythmias are present, marked individual differences in RV MAP duration are present and correspond with pathological asynchrony of ventricular repolarization." | 3.67 | Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes. ( Bonatti, V; Botti, G; Rolli, A, 1985) |
| "A 67 year old man with recurrent hypotensive ventricular tachycardia, amiodarone-induced bradyarrhythmias and severe cardiac dysfunction underwent simultaneous implantation of an automatic cardioverter/defibrillator and bipolar atrioventricular (AV) pacemaker." | 3.67 | Combined bipolar dual chamber pacing and automatic implantable cardioverter/defibrillator. ( Kim, SS; Kouchoukos, NT; Lal, R; Ruffy, R, 1986) |
| "In 23 patients with symptomatic severe supraventricular and ventricular tachyarrhythmias the effectiveness and the side effects of a long-term therapy with the class III antiarrhythmic drug Amiodarone (Cordarone) in a dosage of 100-800 mg/die in monotherapy and combination therapy were investigated." | 3.67 | [Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects]. ( Assmann, I, 1985) |
| "Amiodarone, 600 mg orally daily, was used in an attempt to control supraventricular tachyarrhythmias in a patient with the sick sinus syndrome." | 3.66 | Amiodarone-induced ventricular fibrillation. ( Adgey, AA; Geddes, JS; Khan, MM; Logan, KR; McComb, JM, 1980) |
| "Five patients with the bradycardia-tachycardia syndrome have been treated successfully with the antiarrhythmic agent amiodarone." | 3.66 | Use of amiodarone in bradycardia-tachycardia syndrome. ( Brown, AK; Newton, P; Primhak, RA, 1978) |
| "Bradycardia was observed less in the study group (76 ± 29) than in the control group (93 ± 18; P < ." | 2.79 | Effectiveness of biatrial epicardial application of amiodarone-releasing adhesive hydrogel to prevent postoperative atrial fibrillation. ( Feng, XD; Wang, W; Wang, XN; Yuan, XH, 2014) |
| " Adverse events occurred in 17 patients (3 died, 3 had bradycardia that required permanent pacemaker implantation, and 11 had bradycardia requiring a decrease in the dose of antiarrhythmic or rate-controlling medication)." | 2.71 | Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter. ( Hauser, TH; Josephson, ME; Pinto, DS; Zimetbaum, P, 2003) |
| " However, there was no clear dose-response relation observed in this trial with respect to success rates (primary end point), time to first recurrence of tachyarrhythmia (post hoc analysis) or mortality (secondary end point) over 24 h." | 2.68 | Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. ( Chilson, DA; Gomes, A; Levine, JH; Massumi, A; Platia, EV; Scheinman, MM; Winkle, RA; Woosley, RL, 1996) |
| "For patients who have not had sustained ventricular tachycardia or ventricular fibrillation antiarrhythmic therapy should generally be avoided, but may benefit some high risk patients." | 2.40 | Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure. ( Stevenson, WG; Sweeney, MO, 1997) |
| "Drugs can cause cardiac arrhythmias in a number of clinical situations, and many of the implicated agents are used to treat non-cardiac conditions." | 2.40 | Drug-induced cardiac arrhythmias: incidence, prevention and management. ( Doig, JC, 1997) |
| "Amiodarone is an extremely potent drug which is effective for both supraventricular as well as ventricular arrhythmias." | 2.36 | New antiarrhythmic drugs. ( Hess, DS; Scheinman, MM, 1983) |
| "Amiodarone use was associated with higher metoprolol concentrations following adjustment for different covariates (p = ." | 1.91 | Impact of amiodarone use on metoprolol concentrations, α-OH-metoprolol concentrations, metoprolol dosing and heart rate: A cross-sectional study. ( Busseuil, D; de Denus, S; Dubé, MP; Gaulin, MJ; Jutras, M; Leclair, G; Meloche, M; Mongrain, I; Oussaïd, E; Pilon, MO; Robert, S; Tardif, JC, 2023) |
| "Eight patients were hospitalized for bradyarrhythmia." | 1.42 | Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis. ( Cho, I; Hartaigh, Bó; Hwang, ES; Joung, B; Lee, HY; Lee, MH; Mun, HS; Pak, HN; Park, JK; Shin, DG; Uhm, JS, 2015) |
| "When dronedarone injection was preceded by ivabradine, no further decrease in heart rate or change in MAP was observed (N = 6)." | 1.39 | Dronedarone's inhibition of If current is the primary mechanism responsible for its bradycardic effect. ( Belardinelli, L; Machado, AD; Nearing, BD; Sobrado, LF; Varone, BB; Verrier, RL; Zeng, D, 2013) |
| "Ventricular tachycardias have a broad QRS complex (>or=0." | 1.36 | [Life-threatening brady- and tachyarrhythmias]. ( Trappe, HJ, 2010) |
| "We report a case of a patient with paroxysmal atrial fibrillation (PAF) and with a permanent AAIR (bipolar atrial-inhibited adaptive rate) pacemaker who suffered life-threatening episodes of arrhythmias during operation." | 1.33 | Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery. ( Borel, CO; Lin, JA; Wang, WB; Wong, CS; Wu, CT; Yang, CP; Yeh, CC, 2006) |
| "The most prevalent inclusion bradyarrhythmia was > or =second-degree AV block (82%)." | 1.32 | Predictors of in-hospital ventricular fibrillation or torsades de pointes in patients with acute symptomatic bradycardia. ( Almendral, J; Arenal, A; Díaz-Castro, O; Martínez-Selles, M; Puchol, A; Torrecilla, EG, 2004) |
| "Amiodarone has been shown to improve survival in patients with impaired left ventricular function and ventricular trachyarrhythmias." | 1.29 | [Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders]. ( Hofmann, R; Leisch, F, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (27.27) | 18.7374 |
| 1990's | 11 (14.29) | 18.2507 |
| 2000's | 21 (27.27) | 29.6817 |
| 2010's | 21 (27.27) | 24.3611 |
| 2020's | 3 (3.90) | 2.80 |
| Authors | Studies |
|---|---|
| Lam, JC | 1 |
| Stevenson, B | 1 |
| Lee, YG | 1 |
| Maurer, J | 1 |
| Patanwala, AE | 1 |
| Radosevich, JJ | 1 |
| Robert, S | 1 |
| Pilon, MO | 1 |
| Oussaïd, E | 1 |
| Meloche, M | 1 |
| Leclair, G | 1 |
| Jutras, M | 1 |
| Gaulin, MJ | 1 |
| Mongrain, I | 1 |
| Busseuil, D | 1 |
| Tardif, JC | 1 |
| Dubé, MP | 1 |
| de Denus, S | 1 |
| Monoe, C | 1 |
| Shimizu, H | 1 |
| Kitaguchi, K | 1 |
| Funakoshi, H | 1 |
| Rivinius, R | 1 |
| Helmschrott, M | 1 |
| Ruhparwar, A | 1 |
| Darche, FF | 1 |
| Thomas, D | 1 |
| Bruckner, T | 1 |
| Katus, HA | 1 |
| Doesch, AO | 1 |
| Maghrabi, K | 1 |
| Uzun, O | 1 |
| Kirsh, JA | 1 |
| Balaji, S | 1 |
| Von Bergen, NH | 1 |
| Sanatani, S | 1 |
| Dalgaard, F | 1 |
| Pallisgaard, JL | 1 |
| Lindhardt, TB | 1 |
| Torp-Pedersen, C | 2 |
| Gislason, GH | 1 |
| Ruwald, MH | 1 |
| Sobrado, LF | 1 |
| Varone, BB | 1 |
| Machado, AD | 1 |
| Nearing, BD | 1 |
| Zeng, D | 1 |
| Belardinelli, L | 1 |
| Verrier, RL | 1 |
| Feng, XD | 1 |
| Wang, XN | 1 |
| Yuan, XH | 1 |
| Wang, W | 1 |
| Kim, HL | 1 |
| Seo, JB | 1 |
| Chung, WY | 1 |
| Kim, SH | 1 |
| Kim, MA | 1 |
| Zo, JH | 1 |
| Jennings, DL | 1 |
| Martinez, B | 1 |
| Montalvo, S | 1 |
| Lanfear, DE | 1 |
| Renet, S | 1 |
| Chaumais, MC | 1 |
| Antonini, T | 1 |
| Zhao, A | 1 |
| Thomas, L | 1 |
| Savoure, A | 1 |
| Samuel, D | 1 |
| Duclos-Vallée, JC | 1 |
| Algalarrondo, V | 1 |
| Back, DJ | 1 |
| Burger, DM | 1 |
| Shin, DG | 1 |
| Cho, I | 1 |
| Hartaigh, Bó | 1 |
| Mun, HS | 1 |
| Lee, HY | 1 |
| Hwang, ES | 1 |
| Park, JK | 1 |
| Uhm, JS | 1 |
| Pak, HN | 1 |
| Lee, MH | 1 |
| Joung, B | 1 |
| Brainard, DM | 1 |
| McHutchison, JG | 1 |
| Fontaine, H | 1 |
| Lazarus, A | 1 |
| Pol, S | 1 |
| Pecriaux, C | 1 |
| Bagate, F | 1 |
| Sultanik, P | 1 |
| Boueyre, E | 1 |
| Corouge, M | 1 |
| Mallet, V | 1 |
| Vallet-Pichard, A | 1 |
| Sogni, P | 1 |
| Duboc, D | 1 |
| Ghembaza, Mel A | 1 |
| Lounici, A | 1 |
| Van Gelder, IC | 1 |
| Rienstra, M | 1 |
| Crijns, HJ | 2 |
| Olshansky, B | 1 |
| Hohnloser, SH | 2 |
| van Eickels, M | 1 |
| Gaudin, C | 1 |
| Page, RL | 1 |
| Connolly, SJ | 1 |
| Stiefelhagen, P | 1 |
| Bariş, S | 1 |
| Güzeltaş, A | 1 |
| Seymen, G | 1 |
| Ozyilmaz, I | 1 |
| Güler Eroğlu, A | 1 |
| Oztunç, F | 1 |
| González Oliva, JC | 1 |
| Saurina i Solé, A | 1 |
| Pou Potau, M | 1 |
| Salas Gama, KR | 1 |
| Ramírez de Arellano Serna, M | 1 |
| Trappe, HJ | 1 |
| Jan, SL | 1 |
| Fu, YC | 1 |
| Lin, MC | 1 |
| Hwang, B | 1 |
| Khalil, MA | 1 |
| Al-Agaty, AE | 1 |
| Ali, WG | 1 |
| Abdel Azeem, MS | 1 |
| Immordino, L | 1 |
| Connolly, S | 1 |
| Crijns, H | 1 |
| Roy, D | 1 |
| Capucci, A | 1 |
| Radzik, D | 1 |
| Aliot, E | 1 |
| Hohnloser, S | 1 |
| Kowey, P | 1 |
| Dias Da Silva, VJ | 2 |
| Gnecchi-Ruscone, T | 1 |
| Lavelli, B | 1 |
| Bellina, V | 1 |
| Manzella, D | 1 |
| Porta, A | 1 |
| Malliani, A | 1 |
| Montano, N | 2 |
| Essebag, V | 2 |
| Hadjis, T | 2 |
| Platt, RW | 2 |
| Pilote, L | 2 |
| Goldstein, DR | 1 |
| Coffey, CS | 1 |
| Benza, RL | 1 |
| Nanda, NC | 1 |
| Bourge, RC | 1 |
| Hauser, TH | 1 |
| Pinto, DS | 1 |
| Josephson, ME | 1 |
| Zimetbaum, P | 1 |
| Arxer, A | 1 |
| Novoa, L | 1 |
| Vieito Amor, M | 1 |
| Hernández Iniesta, J | 1 |
| Villalonga, A | 1 |
| Díaz-Castro, O | 1 |
| Puchol, A | 1 |
| Almendral, J | 1 |
| Torrecilla, EG | 1 |
| Arenal, A | 1 |
| Martínez-Selles, M | 1 |
| Abrahamowicz, M | 1 |
| Rajawat, YS | 1 |
| Patel, VV | 1 |
| Gerstenfeld, EP | 1 |
| Nayak, H | 1 |
| Marchlinski, FE | 1 |
| Chen, DY | 1 |
| Cao, J | 1 |
| Zhu, BP | 1 |
| Trombert, V | 1 |
| Graf, C | 1 |
| Lin, JA | 1 |
| Borel, CO | 1 |
| Wang, WB | 1 |
| Wong, CS | 1 |
| Yeh, CC | 1 |
| Yang, CP | 1 |
| Wu, CT | 1 |
| Parsai, C | 1 |
| Bonvini, RF | 1 |
| Schnetzler, B | 1 |
| Sunthorn, H | 1 |
| Wegener, FT | 1 |
| Ehrlich, JR | 1 |
| Reĭngardene, DI | 1 |
| Heger, JJ | 1 |
| Prystowsky, EN | 1 |
| Miles, WM | 1 |
| Zipes, DP | 1 |
| Scheinman, MM | 3 |
| Hess, DS | 1 |
| Conte, MR | 2 |
| Gaita, F | 2 |
| Mangiardi, L | 1 |
| Asteggiano, R | 2 |
| Rosettani, E | 2 |
| Brusca, A | 1 |
| Meulendyk, J | 1 |
| Buchser, E | 1 |
| Chiolero, R | 1 |
| Martin, P | 1 |
| Freeman, J | 1 |
| Forfar, JC | 1 |
| Gribbin, B | 1 |
| Bocchiardo, M | 1 |
| Riccioni, N | 1 |
| Bartolomei, C | 1 |
| McComb, JM | 1 |
| Logan, KR | 1 |
| Khan, MM | 1 |
| Geddes, JS | 1 |
| Adgey, AA | 1 |
| Desnos, M | 1 |
| Hagège, A | 1 |
| Guérot, C | 1 |
| Williamson, BD | 1 |
| Hummel, J | 1 |
| Niebauer, M | 1 |
| Man, KC | 1 |
| Strickberger, SA | 1 |
| Daoud, E | 1 |
| Morady, F | 1 |
| Magee, LA | 1 |
| Downar, E | 1 |
| Sermer, M | 1 |
| Boulton, BC | 1 |
| Allen, LC | 1 |
| Koren, G | 1 |
| Schwartz, J | 1 |
| Rafael, C | 1 |
| Rozenfeld, V | 1 |
| Abu-Much, Z | 1 |
| Schoham, H | 1 |
| Hancock, EW | 2 |
| Levine, JH | 1 |
| Massumi, A | 1 |
| Winkle, RA | 1 |
| Platia, EV | 1 |
| Chilson, DA | 1 |
| Gomes, A | 1 |
| Woosley, RL | 1 |
| Hofmann, R | 1 |
| Leisch, F | 1 |
| Van Mieghem, W | 1 |
| Tits, G | 1 |
| Demuynck, K | 1 |
| Lacquet, L | 1 |
| Deneffe, G | 1 |
| Tjandra-Maga, T | 1 |
| Demedts, M | 1 |
| Stevenson, WG | 1 |
| Sweeney, MO | 1 |
| Doig, JC | 1 |
| Dörge, H | 1 |
| Schoendube, FA | 1 |
| Schoberer, M | 1 |
| Stellbrink, C | 1 |
| Voss, M | 1 |
| Messmer, BJ | 1 |
| Cavalcante Viana, PC | 1 |
| de Melo Alves, R | 1 |
| Salgado, HC | 1 |
| Fazan, R | 1 |
| Hilleman, DE | 1 |
| Spinler, SA | 1 |
| Cosma, C | 1 |
| Crepin, D | 1 |
| Py, J | 1 |
| Posse, RA | 1 |
| Zuelgaray, JT | 1 |
| Brown, AK | 1 |
| Primhak, RA | 1 |
| Newton, P | 1 |
| Modica, G | 1 |
| Di Fazzio, S | 1 |
| Timpanaro, V | 1 |
| Centamore, G | 1 |
| Guarnieri, T | 1 |
| Tomaselli, G | 1 |
| Griffith, LS | 1 |
| Brinker, J | 1 |
| Bonatti, V | 1 |
| Rolli, A | 1 |
| Botti, G | 1 |
| Murthy, VS | 1 |
| Hwang, TF | 1 |
| Leor, J | 1 |
| Levartowsky, D | 1 |
| Sharon, C | 1 |
| Farfel, Z | 1 |
| Helmy, I | 1 |
| Herre, JM | 1 |
| Gee, G | 1 |
| Sharkey, H | 1 |
| Malone, P | 1 |
| Sauve, MJ | 1 |
| Griffin, JC | 1 |
| Ruffy, R | 1 |
| Lal, R | 1 |
| Kouchoukos, NT | 1 |
| Kim, SS | 1 |
| Ben-Chetrit, E | 1 |
| Ackerman, Z | 1 |
| Eliakim, M | 1 |
| Assmann, I | 1 |
| Liberman, BA | 1 |
| Teasdale, SJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Study Using Intra-Pericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation (POAF) in Patients Undergoing Cardiac Arterial Bypass Grafting and/or Valve Surgery[NCT06063538] | Early Phase 1 | 63 participants (Anticipated) | Interventional | 2023-11-30 | Not yet recruiting | ||
| A Placebo-controlled,Double-blind,Parallel Arm Trial to Assess the Efficacy of Dronedarone 400mg Bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter (AF/AFL)[NCT00174785] | Phase 3 | 4,628 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence Post Ablation: The EDORA Trial[NCT04704050] | Phase 4 | 22 participants (Actual) | Interventional | 2021-05-15 | Terminated (stopped due to Sponsor withdrew funding) | ||
| Pragmatic Randomized Clinical Trial of Early Dronedarone Versus Usual Care to Change and Improve Outcomes in Persons With First-Detected Atrial Fibrillation[NCT05130268] | Phase 4 | 3,000 participants (Anticipated) | Interventional | 2021-10-29 | Active, not recruiting | ||
| Using Time-dependent Intravenous Infusions of Amiodarone for Conversions to Sinus Rhythms in Patients With Paroxysmal Atrial Fibrillation[NCT03432663] | Phase 4 | 60 participants (Actual) | Interventional | 2008-08-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The considered event is cardiovascular death, as assessed by the blinded adjudication of the Steering Committee. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period. (NCT00174785)
Timeframe: minimum follow-up duration: 1 year ; maximum: 2.5 years
| Intervention | participants (Number) |
|---|---|
| Dronedarone 400mg Bid | 63 |
| Placebo | 90 |
The considered event is cardiovascular death, as assessed by the Investigator. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period. (NCT00174785)
Timeframe: minimum follow-up duration: 1 year ; maximum: 2.5 years
| Intervention | participants (Number) |
|---|---|
| Dronedarone 400mg Bid | 65 |
| Placebo | 94 |
The considered event is death from any cause. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period. (NCT00174785)
Timeframe: minimum follow-up duration: 1 year ; maximum: 2.5 years
| Intervention | participants (Number) |
|---|---|
| Dronedarone 400mg Bid | 116 |
| Placebo | 139 |
The considered event is the first hospitalization for cardiovascular reason, as assessed by the Investigator. The analysis is performed on the time from randomization to this event. The Measured Values table below presents the numbers of patients with the event at the end of the study period. (NCT00174785)
Timeframe: minimum follow-up duration: 1 year ; maximum: 2.5 years
| Intervention | participants (Number) |
|---|---|
| Dronedarone 400mg Bid | 675 |
| Placebo | 859 |
The primary event is the first hospitalization for cardiovascular reason or death from any cause, whichever is earlier, as assessed by the investigator. The primary efficacy analysis is performed on the time from randomization to this primary event. The Measured Values table below presents the numbers of patients with the event at the end of the study period. (NCT00174785)
Timeframe: minimum follow-up duration: 1 year ; maximum: 2.5 years
| Intervention | participants (Number) |
|---|---|
| Dronedarone 400mg Bid | 734 |
| Placebo | 917 |
7 reviews available for amiodarone and Bradycardia
| Article | Year |
|---|---|
Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biological Availability; Bradycardia; Drug Interactions; Heart F | 2015 |
Rate control in atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Age Factors; Amiodarone; Anti-Arrhythmia Agents; Atenolol; Atrial Fibri | 2016 |
Clinical use and pharmacology of amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Autonomic Ne | 1984 |
New antiarrhythmic drugs.
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Blood Circulation; Bradycardia; Diltiazem; Half | 1983 |
Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Catheter Ablation; Defibrillators, Implantable; Ele | 1997 |
Drug-induced cardiac arrhythmias: incidence, prevention and management.
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anti-Infective Agents; | 1997 |
Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cohort Studies; Humans; Hypote | 2002 |
7 trials available for amiodarone and Bradycardia
| Article | Year |
|---|---|
Effectiveness of biatrial epicardial application of amiodarone-releasing adhesive hydrogel to prevent postoperative atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiac Surgical Proced | 2014 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2009 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2009 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2009 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2009 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2009 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2009 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2009 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2009 |
Effect of dronedarone on cardiovascular events in atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2009 |
Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flut | 2003 |
Treatment of the bradycardia-tachycardia syndrome with low doses of amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Clinical Trials as Topic; Female; Humans; Male; Middle A | 1981 |
Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group.
Topics: Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Bradycardia; Cause of Death; Chi-Square Di | 1996 |
Verapamil as prophylactic treatment for atrial fibrillation after lung operations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Humans; Hypotension; Incidence | 1996 |
Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Coronary Artery Bypass; Female | 2000 |
63 other studies available for amiodarone and Bradycardia
| Article | Year |
|---|---|
Intravenous to Oral Transition of Amiodarone (IOTA): Effect of Various Durations of Overlap on Atrial Fibrillation Recurrence After Cardiothoracic Surgery.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Humans; | 2022 |
Impact of amiodarone use on metoprolol concentrations, α-OH-metoprolol concentrations, metoprolol dosing and heart rate: A cross-sectional study.
Topics: Adult; Amiodarone; Bradycardia; Cross-Sectional Studies; Cytochrome P-450 CYP2D6; Heart Rate; Humans | 2023 |
Severe Bradycardia Induced by Sofosbuvir and Amiodarone which Resolved after the Discontinuation of Both Drugs.
Topics: Amiodarone; Antiviral Agents; Bradycardia; Drug Interactions; Drug Therapy, Combination; Hepatitis C | 2020 |
Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Female; Follow-Up | 2017 |
Cardiovascular Collapse with Intravenous Amiodarone in Children: A Multi-Center Retrospective Cohort Study.
Topics: Administration, Intravenous; Adolescent; Age Distribution; Amiodarone; Anti-Arrhythmia Agents; Blood | 2019 |
Rate and rhythm therapy in patients with atrial fibrillation and the risk of pacing and bradyarrhythmia.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Denmark; Fe | 2019 |
Dronedarone's inhibition of If current is the primary mechanism responsible for its bradycardic effect.
Topics: Amiodarone; Analysis of Variance; Animals; Arterial Pressure; Benzazepines; Blood Pressure; Bradycar | 2013 |
The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Block; Bradycardia; | 2014 |
In brief: severe bradycardia with sofosbuvir and amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antiviral Agents; Bradycardia; Drug Interactions; Drug Labeling; | 2015 |
Extreme bradycardia after first doses of sofosbuvir and daclatasvir in patients receiving amiodarone: 2 cases including a rechallenge.
Topics: Amiodarone; Antiviral Agents; Bradycardia; Carbamates; Drug Therapy, Combination; Electrocardiograph | 2015 |
Interaction between amiodarone and sofosbuvir-based treatment for hepatitis C virus infection: potential mechanisms and lessons to be learned.
Topics: Amiodarone; Bradycardia; Drug Therapy, Combination; Electrocardiography; Female; Humans; Imidazoles; | 2015 |
Cardiovascular Events of Electrical Cardioversion Under Optimal Anticoagulation in Atrial Fibrillation: The Multicenter Analysis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiovascular Diseases; | 2015 |
Bradyarrhythmias Associated with Sofosbuvir Treatment.
Topics: Amiodarone; Antiviral Agents; Bradycardia; Female; Humans; Male; Uridine Monophosphate | 2015 |
Bradyarrhythmias Associated with Sofosbuvir Treatment.
Topics: Aged; Amiodarone; Antiviral Agents; Bradycardia; Drug Therapy, Combination; Female; Hepatitis C, Chr | 2015 |
Sofosbuvir + amiodarone: bradycardia and conduction disturbances.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antiviral Agents; Arrhythmias, Cardiac; Bradycardia; Brugada Syn | 2015 |
Bradyarrhythmia induced by amiodarone-sofosbuvir co-administration.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradycardia; Drug Interactions; Drug Thera | 2016 |
[Cardiac symptoms in endocrinologic disorders. Heart illness caused by the thyroid gland].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Atrial Fi | 2009 |
Intractable atrial flutter presented with severe bradycardia in an infant.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Bradycardia; Cataract; Electric Countershock; El | 2009 |
[Difficult-to-treat atrial fibrillation in a patient on haemodialysis].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Atrial Fibrillation; Bisoprolol; Bradycardia; Calcium | 2010 |
[Life-threatening brady- and tachyarrhythmias].
Topics: Adenosine; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atropine; Brad | 2010 |
Precordial thump in a newborn with refractory supraventricular tachycardia and cardiovascular collapse after amiodarone administration.
Topics: Amiodarone; Bradycardia; Cardiopulmonary Resuscitation; Drug Resistance; Electrocardiography; Emerge | 2012 |
A comparative study between amiodarone and magnesium sulfate as antiarrhythmic agents for prophylaxis against atrial fibrillation following lobectomy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Female; Humans; Infusion | 2013 |
Effects of dronedarone started rapidly after amiodarone discontinuation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Dronedarone; Drug Substi | 2013 |
Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atropine; Autonomic Fibers, Preganglionic; Baroreflex; | 2002 |
Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardiac Pacing, Artifici | 2003 |
Relative perioperative bradycardia does not lead to adverse outcomes after cardiac transplantation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Case-Control Studies; Heart Transplantation; Humans | 2003 |
[Bradycardia-tachycardia syndrome during spinal anesthesia].
Topics: Aged; Amiodarone; Anesthesia, Spinal; Aneurysm; Anti-Arrhythmia Agents; Anticoagulants; Bradycardia; | 2003 |
Predictors of in-hospital ventricular fibrillation or torsades de pointes in patients with acute symptomatic bradycardia.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Electrocardiography | 2004 |
Effect of amiodarone dose on the risk of permanent pacemaker insertion.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cohort Stud | 2004 |
Advantages and pitfalls of combining device-based and pharmacologic therapies for the treatment of ventricular arrhythmias: observations from a tertiary referral center.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Combined Modality Therapy; Defibrillators, Implanta | 2004 |
Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cardi | 2006 |
[Bradycardia in an elderly woman caused by amiodarone assessed by ECG].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Electrocardiography; Female; Hum | 2006 |
Anesthetic management of an AAI pacemaker patient with paroxysmal atrial fibrillation during colorectal surgery.
Topics: Aged; Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Atropine; Bradyc | 2006 |
Cardiac transplantation in a patient with emotionally triggered implantable cardioverter defibrillator storms.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anxiety; Bradycardia; Defibrillators, Implantable; Electric | 2007 |
Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Electrocardiography; Humans; L | 2008 |
[Effect of treatment with amiodarone on sinus node function].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Drug Administration Schedule; | 2007 |
[Amiodarone in paroxysmal supra-ventricular tachycardias associated with sinus bradycardia].
Topics: Adult; Aged; Amiodarone; Benzofurans; Bradycardia; Female; Humans; Male; Middle Aged; Tachycardia, P | 1983 |
Anesthetic considerations with amiodarone: report of a case.
Topics: Aged; Amiodarone; Anesthesia, General; Benzofurans; Bradycardia; Coronary Artery Bypass; Heart Block | 1984 |
Amiodarone-induced haemodynamic complications during anaesthesia.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Female; Humans; Hypotension; Intraoperative Complication | 1983 |
Torsade de pointes after amiodarone withdrawal; effects of mild hypokalaemia on repolarization.
Topics: Amiodarone; Benzofurans; Bradycardia; Cardiac Pacing, Artificial; Electrocardiography; Female; Human | 1984 |
[Amiodarone in the bradycardia-tachycardia syndrome. 2-year follow-up].
Topics: Adult; Aged; Amiodarone; Benzofurans; Bradycardia; Female; Follow-Up Studies; Humans; Male; Middle A | 1982 |
Amiodarone-induced ventricular fibrillation.
Topics: Amiodarone; Benzofurans; Bradycardia; Cardiac Pacing, Artificial; Electric Countershock; Electrocard | 1980 |
[Hypertrophic cardiomyopathy: place and limitations of medical therapy].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Calcium Channel Blocke | 1995 |
Bradycardia-facilitated polymorphic ventricular tachycardia caused by amiodarone after radiofrequency modification of atrioventricular conduction.
Topics: Aged; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Bradycardia; Catheter Ablation; Electr | 1995 |
Pregnancy outcome after gestational exposure to amiodarone in Canada.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Canada; Cohort St | 1995 |
Change of the degree of septal hypertrophy in hypertrophic obstructive cardiomyopathy under procainamide treatment. A case report.
Topics: Aged; Aged, 80 and over; Amiodarone; Bradycardia; Cardiomyopathy, Hypertrophic; Contraindications; E | 1995 |
Slow pulse in a woman with heart failure.
Topics: Aged; Amiodarone; Bradycardia; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure | 1994 |
[Symptomatic bradycardia with amiodarone in patients with pre-existing conduction disorders].
Topics: Aged; Amiodarone; Bradycardia; Bundle-Branch Block; Dose-Response Relationship, Drug; Drug Administr | 1995 |
Bradycardia with a changing P-R interval.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Electrocardiography; Fem | 2001 |
Antihypertensive action of amiodarone in spontaneously hypertensive rats.
Topics: Amiodarone; Animals; Antihypertensive Agents; Blood Pressure; Bradycardia; Diastole; Heart Rate; Hyp | 2001 |
[Action and adverse effects of amiodarone in Wolff-Parkinson-White syndrome].
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Female; Heart Rate; Humans; Tachycardia, Paroxysmal; Wol | 1979 |
Use of amiodarone in bradycardia-tachycardia syndrome.
Topics: Amiodarone; Benzofurans; Bradycardia; Humans; Tachycardia | 1979 |
Use of amiodarone in bradycardia-tachycardia syndrome.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Corneal Diseases; Female; Humans; Male; Middle Aged; Syn | 1978 |
[Use of amiodarone in atrial tachyarrhythmias associated with sinus bradycardia. Evaluation of the results by means of continuous monitoring].
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Electrocardiography; Exercise Test; Humans; Male; Middle | 1977 |
The interaction of antiarrhythmic drugs and the energy for cardioversion of chronic atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Cerebrovascular Disorders; Chr | 1991 |
Monophasic action potential studies in human subjects with prolonged ventricular repolarization and long QT syndromes.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Complexes, Premature | 1985 |
Antiarrhythmic drugs and the modulation of autonomic control of heart rate in rabbits.
Topics: Adenosine; Amiodarone; Animals; Anti-Arrhythmia Agents; Bradycardia; Female; Heart Conduction System | 1986 |
Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol.
Topics: Amiodarone; Atenolol; Bradycardia; Cardiomyopathy, Hypertrophic; Drug Interactions; Drug Therapy, Co | 1988 |
Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.
Topics: Amiodarone; Arrhythmias, Cardiac; Bradycardia; Cardiac Pacing, Artificial; Electrocardiography; Emer | 1988 |
Combined bipolar dual chamber pacing and automatic implantable cardioverter/defibrillator.
Topics: Aged; Amiodarone; Bradycardia; Cardiac Pacing, Artificial; Electric Countershock; Electrodes, Implan | 1986 |
Amiodarone-associated hypothyroidism--a possible cause of digoxin intoxication.
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Digoxin; Drug Interactions; Electrocardiography; Female; | 1985 |
[Long-term therapy with amiodarone in tachyarrhythmias--report on various experiences with special reference to its side effects].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Bradycardia; Drug Therapy, Combination; Elec | 1985 |
Anaesthesia and amiodarone.
Topics: Adult; Aged; Amiodarone; Anesthesia, General; Anesthetics; Atropine; Benzofurans; Bradycardia; Cardi | 1985 |